Literature DB >> 11993592

Molecular characterisation of human campylobacteriosis in Northern Ireland: evidence of clonal stability.

T Matsui1, J E Moore, C Patterson, B C Millar, M Matsuda.   

Abstract

BACKGROUND: No study has compared Campylobacter isolates from a human source in Northern Ireland over an extended period of time. AIM: To investigate the clonal stability of thermophilic campylobacters isolated from acute bacterial enteritis in Northern Ireland from 1992 to 1999.
METHODS: Human isolates (n=272), originating from faeces, were characterised at the sub-species level using enterobacterial repetitive intergenic consensus sequence (ERIC2)--random amplification of polymorphic DNA (RAPD) typing.
RESULTS: Thirteen genotypes were identified where three types, namely ERIC A, ERIC C and ERIC I, accounted for 28.3%, 14.3% and 13.6%, respectively. There were no significant associations (p>0.05) between sex, age groupings and year of isolation and ERIC2 genotype, with the exception of ERIC D, which showed a significant decline in isolation with time (p=0.019).
CONCLUSIONS: ERIC genotypes were stable over this period, except genotype C which was lost during this time. Previous molecular typing methods showed campylobacters to be heterogeneous but this study suggests that the local human Campylobacter population consists of several common and stable genotypes. This study has established a database of local ERIC2 genotypes. This methodology may allow the establishment of an all-island database of clinical campylobacters that would be valuable in reducing human campylobacteriosis in Ireland.

Entities:  

Mesh:

Year:  2002        PMID: 11993592     DOI: 10.1007/bf03168939

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  A study of infectious intestinal disease in England: plan and methods of data collection.

Authors:  D Sethi; J G Wheeler; J M Cowden; L C Rodrigues; P N Sockett; J A Roberts; P Cumberland; D S Tompkins; P G Wall; M J Hudson; P J Roderick
Journal:  Commun Dis Public Health       Date:  1999-06

2.  Repetitive and arbitrary primer DNA sequences in PCR-mediated fingerprinting of outbreak and sporadic isolates of Campylobacter jejuni.

Authors:  M P Iriarte; R J Owen
Journal:  FEMS Immunol Med Microbiol       Date:  1996-08

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Genomic heterogeneity and O-antigenic diversity of Campylobacter upsaliensis and Campylobacter helveticus strains isolated from dogs and cats in Germany.

Authors:  I Moser; B Rieksneuwöhner; P Lentzsch; P Schwerk; L H Wieler
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Comparison of polymerase chain reaction and pulsed-field gel electrophoresis for the epidemiological typing of Campylobacter jejuni.

Authors:  Z Y Shi; P Y Liu; Y J Lau; Y H Lin; B S Hu; H N Tsai
Journal:  Diagn Microbiol Infect Dis       Date:  1996 Nov-Dec       Impact factor: 2.803

6.  PCR-mediated DNA typing of Campylobacter jejuni isolated from patients with recurrent infections.

Authors:  H P Endtz; B A Giesendorf; A van Belkum; S J Lauwers; W H Jansen; W G Quint
Journal:  Res Microbiol       Date:  1993 Nov-Dec       Impact factor: 3.992

7.  Development of species-specific DNA probes for Campylobacter jejuni, Campylobacter coli, and Campylobacter lari by polymerase chain reaction fingerprinting.

Authors:  B A Giesendorf; A van Belkum; A Koeken; H Stegeman; M H Henkens; J van der Plas; H Goossens; H G Niesters; W G Quint
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

  7 in total
  1 in total

1.  Genetic characterization and antibiotic resistance of Campylobacter jejuni isolated from meats, water, and humans in Sweden.

Authors:  H Lindmark; B Harbom; L Thebo; L Andersson; G Hedin; B Osterman; T Lindberg; Y Andersson; A Westöö; E Olsson Engvall
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.